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1202-l 46 impact of Insulin Resistance and Hyperinsulin 
Response on Arterial Stiffness 
Toshihide Hinoi, Hrdeo Sasaki, Chikako lto, Hiroshima A-Bomb Casualty, Hiroshrma, 
Japan 
Background-Cardiovascular disease is the most common cause of disability and death 
among subjects with type 2 diabetes mellitus (DM). Measurement of pulse wave velocity 
(PWV) is a non-invasive method to estimate arterial stiffness. In order to determine the 
effect of diabetes on arterial stiffness, we conducted a large scale and cross-sectional 
study in single center. 
Methods- A total of 11,602 subjects were performed 75g-oral glucose tolerance test 
(OGTT), blood chemistry and PWV measurement, and were enrolled in the present study 
(mean age 64.5+/-8.9 years, 14% hypertension, 56% dyslipidaemia, 37% current 
smoker). We diagnosed, 5,593 were normal, 641 impaired fasting glucose (IFG), 3,360 
impaired glucose tolerance (IGT), and 2,236 Type 2 DM. 
RESULTS-Compared with normal group, abnormal groups (IFG, IGT and type 2 DM) 
had signiftcantly increased PWV(6.4 versus 6.7, 6.9 and 9.lmIsec .p<O.OOl). Multivariate 
analysis showed that age, gender male, systolic blood pressure, serum triglycerides, 2 
hour plasma glucose. and sigma-IRI (sum of insulin yalue in OGTT) were positively cor- 
related with PWV, and lower serum HDL-cholesterol was inversely correlated (all 
P<O.OOl). Linear relationship was appreciated between sigma-IRI and PWV( r=0.966, 
p=o.o14 ). 
CONCLUSION-These results suggest that, in addition to age, sex, systolic blood pres- 
sure and triglycerides, hyper-insulin response as assessed by OGTT is independently 
associated with early atherosclerosis in newly diagnosed type 2 DM. 
1202-l 47 Persistence of Impaired Vascular Function Despite an 
Improved Metabolic Profile Following Three Months of 
Significant Weight Loss 
Robert D. Brook, Robert L. Bard, Louis D’Alecy. Lynn Glazewski, Sanjay Rajagopalan, 
University of Michigan, Ann Arbor, Ml 
Background: Obesity Impairs endothelial function and arterial compliance. We therefore 
sought to determine if weight loss significantly improves vascular health. 
Methods: 43 adults (BMI 2 27 ks/ms) without other risk factors underwent a 3 month trial 
of diet + orlistat (120 mg PO QAC). Endothelial-dependent and independent vasomotion 
were determined by brachral flow-mediated dilatation (FMD) and nitroglycerin-mediated 
dilatation (NMD). Large (LVC) and small (SVC) vessel compliance was determined by 
computerized arterial pulse waveform analysis. Metabolic parameters, C-reactive protein 
(CRP), and asymmetric dimethyl arginine (ADMA) were also assessed. 
Results: Body weight was reduced by an average of 6.6 % after 3 months. BMI (34.9 * 
4.6 to 32.7 f 4.6 kg/m*. p<O.OOl) and waist circumference (107.5 * 10.7 to 102.2 * 15.4 
cm. p=O.OOl) significantly decreased. LDL-C (114 * 27 to 104 * 25 mg/dl, p=O.o05), LDL 
particle concentration (1339 f 359 to 1222 f 325 mmolll, p=O.O09), insulin (8.8 * 4.1 to 
7.4 * 2.7 UU/ml, p=O.O02), and glucose (68.3 * 6.8 to 65.5 * 9.2 mg/dl. p=O.O69) 
improved. Vascular function, CRP, and ADMA were not altered (Table). 
Conclusion: Despite reduced adiposity and a significant improvement in the metabolic 
profile, 3 months of weight reduction did not alter endothelial function or vascular compli- 
ance. These results are important because they demonstrate that a greater amount, or a 
more prolonged time period, of weight loss may be required to restore vascular health in 
overweight adults. 
Baseline Post weight loss P 
FMD (%) 3.66 * 3.54 3.74 * 3.76 0.66 
NMD (%) 17.16 * 5.69 18.67 * 7.11 0.13 
SVC ((ml/mm Hg) x 100) 10.2 * 3.6 10.5 * 5.7 0.74 
LVC ((ml/mm Hg) x 100) 16.6 zt 6.3 17.7 * 6.6 0.51 
ADMA (MM) 0.95 *0.13 0.95 * 0.15 0.75 
CRP (mg/dL) 0.47 * 0.41 0.40 * 0.45 0.23 
1202-148 C-Type Natriuretic Peptide and Adrenomedullin Levels 
in Patients With Obstructive Sleep Apnea 
Robert Walk, Anna Svatikova, Abu Shamsuzzaman, Mikolaj Winnicki. Carolyn Fieseler, 
Bruce Johnson, Virend K. Somers, Mayo Clinic, Rochester, MN 
BACKGROUND. Obstructive sleep apnea (OSA) has been related to an increased rnci- 
dence of hypertension, atherosclerosis, arterial thrombosis and other cardiovascular dis- 
eases. C-type natriuretic peptide (CNP) is a novel endothelium-derived mediator with 
vasodilatory, anti-atherogenic and anti-thrombotic properties. We hypothesized that OSA 
might be associated with reduced plasma CNP concentration. METHODS. Plasma CNP 
levels were measured during the night (at 9:30 p.m., 2 a.m., 6 a.m.) in 15 healthy male 
OSA patients and in 10 matched controls. RESULTS. Baseline CNP levels before sleep 
were significantly lower in the OSA than in the control group (21.3i2.3 vs. 32.9*4.0 pg/ 
ml, respectively, p=O.O13). During the night, there was a gradual decrease rn CNP levels 
in the control group (from 32.9k4.0 to 21.0*3.1 pglml, p=O.OlZ). However, in the OSA 
group, CNP levels increased during the period of untreated sleep apnea, and subse- 
quently decreased in response to CPAP therapy. In contrast to CNP, plasma levels of 
another endothelium-derived vasodilator, adrenomedullin, were not affected by OSA 
(either chronically or acutely). CONCLUSION. OSA exerts a twofold effect on CNP regu- 
lation. Baseline CNP production is markedly reduced, whereas acute episodes of sleep 
apnea during the night cause a modest, but significant increase in plasma CNP levels. 
1202-149 Interactive Effects of the ACE DD Polymorphism With 
the NOS Ill Homozygous G649T (Glu298-Asp) Variant in 
Determining Endothelial Function in Coronary Artery 
Disease 
Michael A. Schmidt Anjan Chakrabarti, Dana Pfeninnger, Nice Kacirotti, Claire 
Duvernoy, Anthony Killeen, Robert D. Brook, Sanjay Rajagopalan. University of 
Michigan, Ann Arbor, MI 
Background: The products of Nitric Oxide Synthase (NOS) and Angiotensin Converting 
Enzyme (ACE) play a critical role rn determining ve~~sl wall structure and function. Poly- 
morphisms in both genes have been independently demonstrated to influence propensity 
to cardiovascular events. We wished to determine the influence of the homozygous 
G649T(Gl@s + Asp) polymorphism in NOS Ill on peripheral conduit artery endothelial 
function and to elucidate the modifier role. if any, of a common ACE polymorphism. 
Methods: 397 consecutive subiects oresentina to the cardiac catheterization laboratow 
of the University of Michigan over a period of 16 months were recruited. DNA was 
extracted and PCR analvsis for ACE and NOS oolvmorohisms oerformed. Patients with 
homozygosity for G649T at both loci (TT) who belong to DD and II ACE genotype 
(groups 1 and 2) and those who are negative for this polymorphism (GG) and belong to 
either DD or II genotype (groups 3 and 4) were identified. The four groups then under- 
went determination of conduit endothelial function. Heterozygosity GIL?~* -Asp or the ID 
variant of the ACE were not studied. 
Results Median FMD value in the TT-DD group was 0.20 (-3.17, 2 01) compared to 
2.23% (-0.29.4.17) in the GG-II group. Median values in the TT-II and the GG-DD groups 
were 3.04(-1.16. 6.61) and 2.46% (-1.63. 6.52) respectively. These values were not sta- 
tistically significant (p>O.O5 by one way ANOVA). Median nitroglycerin mediated dilation 
in the four groups did not differ between the four groups (p=NS by ANOVA). Atheroscle- 
rosis burden as assessed by angiography were not different across the groups. 
Conclusions: The homozygous NOS III variant (GG) status does not seem to interact 
additively with the ACE homozygous DD genotype, in determining flow mediated vasodi- 
lation in individuals with established atherosclerosis and preexistent endothelial dys- 
function 
1202-l 50 Effect of a Severe Coronary Stenosis and Percutaneous 
Cornary Intervention on the Coronary Microcirculation 
Koen M. Maraues. Hugo J. Spruijt, Nice Westerhof, Cees A. Visser. Frans C. Visser, VU 
University Medical Center, Amsterdam, The Netherlands, ICaR-VU, Amsterdam, The 
Netherlands 
Background Classically, epicardial stenoses are thought to exert their clinical effect by 
limitation of the maximal flow capacity. In animal studies, artificial coronary stenoses 
have been shown to decrease the microvascular resistance (MR) to compensate for the 
epicardial obstruction. In human studies, data on the effect of atherosclerotic epicardial 
stenoses on the MR are conflicting. A constrictor response of the microcirculation (MC), 
supplied by a severely narrowed epicardial coronary, was found to pacing induced tachy- 
cardia. 
Methods We simultaneously measured mean flow velocity (APV) and distal coronary 
pressure (Pd) distal to a coronary stenosis, at baseline and maximal hyperemia, induced 
by adenosine. The MR was defined as the hyperemic ratio of Pd by APV. Data were 
acquired in 23 normal coronaries (group A), in 54 arteries with an intermediate stenosis 
without ischemia (group B), and rn 29 stenoses with evidence of ischemia. detected by 
non-invasive tests (group C), and in 14 arteries (group D) immediately after PCI. 
Results A significant difference was found between the MR of the different groups. The 
MR in group C was statistically higher (‘~‘0.05) compared to the other groups and the 
MR after PCI was significantly (‘p<O.O5) lower. 
Conclusion We found that the MR in areas perfused by severe coronary stenoses is ele- 
vated, suggesting that the MC can aggravate the effect of a severe coronary stenosis. 
Immediately post PCI the MR was significantly lower compared to normal arteries. 
APV(cm/sec) 
Pd (mm Hg) 
MR (mmHg.sec/cm) 
group A 
50*11 
92*15 
2.0*0.5 
group B 
46tl4 
65*14 
2.1+0 7 
group c 
33+15 
64+15 
2.6kl.4. 
group D 
56+17 
60+12 
1.7+0.6’ 
1202-151 Direct Vasodilatory Effects of the Antidepressant 
Sertraline in the Human Internal Mammary Artery 
Joost P. van Melle, Hendrik Buikema, Maarten P. van den Berq, Azuwerus van B&en, 
Mariolein Hensens. Wiek H. van Gilst. Thoraxcenterof the Universrtv Hosoital 
Groningen, Groningen, The Netherlands 
Background: Depression is associated with a significantly increased risk of cardiac 
events in patients who had coronary artery bypass graft (CABG) surgery. It is unknown 
whether antidepressive medication can improve cardiac prognosis in these patients. 
Because Selective Serotonin Re-uptake Inhibitors (SSRls) are frequently prescribed anti- 
depressants, we studred the vasoactive response of human Internal Mammary Artery 
(IMA) preparations to sertraline, whtch is one of the SSRls. 
Methods: IMAs (n=22) were harvested during CABG surgery and cut into rings. In 
